Literature DB >> 20734109

Salarin C, a member of the salarin superfamily of marine compounds, is a potent inducer of apoptosis.

Nathalie Ben-Califa1, Ashgan Bishara, Yoel Kashman, Drorit Neumann.   

Abstract

The continuous emergence of new diseases and the development of drug-resistant cancers necessitate the development of new drugs with novel mechanisms of action. The richest marine source of natural anti-cancer products has been soft-bodied organisms that lack physical defenses against their predators, and hence rely on chemical defense mechanisms using cytotoxic secondary metabolites. Bio-guided (brine shrimp test) separation of CHCl(3)-CH(3)OH (1:1) extract from the Madagascar Fascaplysinopsis sp. sponge provided several new compounds. Here we focused on the biological activity of a panel of novel natural compounds, salarins A-J. Of these, salarin C was the most potent inhibitor of proliferation, as demonstrated on the K562 leukemia cell line. Salarin C-treated K562 cells underwent apoptotic death as monitored by cell-cycle analysis, annexin V/propidium iodide staining, cleavage of poly-ADP-ribose polymerase (PARP) and caspase 3, and caspase 9 levels. The experimental approach described herein is an essential step towards identifying the cellular pathway(s) affected by salarin C and producing potent synthetic derivatives of salarin C with potential future uses as basic research tools and/or drugs and drug leads.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20734109     DOI: 10.1007/s10637-010-9521-4

Source DB:  PubMed          Journal:  Invest New Drugs        ISSN: 0167-6997            Impact factor:   3.850


  15 in total

Review 1.  Natural compounds for cancer treatment and prevention.

Authors:  Stefania Nobili; Donatella Lippi; Ewa Witort; Martino Donnini; Letizia Bausi; Enrico Mini; Sergio Capaccioli
Journal:  Pharmacol Res       Date:  2009-02-07       Impact factor: 7.658

Review 2.  Marine macrolides, a promising source of antitumor compounds.

Authors:  José G Napolitano; Antonio H Daranas; Manuel Norte; José J Fernández
Journal:  Anticancer Agents Med Chem       Date:  2009-02       Impact factor: 2.505

3.  Properties of the K562 cell line derived from a patient with chronic myeloid leukemia.

Authors:  B B Lozzio; C B Lozzio
Journal:  Int J Cancer       Date:  1977-01       Impact factor: 7.396

4.  Phosphorylation of erythropoietin receptors in the endoplasmic reticulum by pervanadate-mediated inhibition of tyrosine phosphatases.

Authors:  J Cohen; H Altaratz; Y Zick; U Klingmüller; D Neumann
Journal:  Biochem J       Date:  1997-10-15       Impact factor: 3.857

5.  Caspase-mediated cleavage of p21Waf1/Cip1 converts cancer cells from growth arrest to undergoing apoptosis.

Authors:  Y Zhang; N Fujita; T Tsuruo
Journal:  Oncogene       Date:  1999-02-04       Impact factor: 9.867

6.  The Bcl-2 family in autoimmune and degenerative disorders.

Authors:  Delphine Mérino; Philippe Bouillet
Journal:  Apoptosis       Date:  2009-04       Impact factor: 4.677

7.  Taumycins A and B, two bioactive lipodepsipeptides from the Madagascar sponge Fascaplysinopsis sp.

Authors:  Ashgan Bishara; Amira Rudi; Maurice Aknin; Drorit Neumann; Nathalie Ben-Califa; Yoel Kashman
Journal:  Org Lett       Date:  2008-09-10       Impact factor: 6.005

Review 8.  Caspase-independent pathways of programmed cell death: the unraveling of new targets of cancer therapy?

Authors:  C Constantinou; K A Papas; A I Constantinou
Journal:  Curr Cancer Drug Targets       Date:  2009-09       Impact factor: 3.428

9.  Salarins a and B and tulearin a: new cytotoxic sponge-derived macrolides.

Authors:  Ashgan Bishara; Amira Rudi; Maurice Aknin; Drorit Neumann; Nathalie Ben-Califa; Yoel Kashman
Journal:  Org Lett       Date:  2007-12-18       Impact factor: 6.005

10.  p53 in chronic myelogenous leukemia. Study of mechanisms of differential expression.

Authors:  M Lübbert; C W Miller; L Crawford; H P Koeffler
Journal:  J Exp Med       Date:  1988-03-01       Impact factor: 14.307

View more
  8 in total

1.  Salarin C inhibits the maintenance of chronic myeloid leukemia progenitor cells.

Authors:  E Del Poggetto; M Tanturli; N Ben-Califa; A Gozzini; I Tusa; G Cheloni; I Marzi; M G Cipolleschi; Y Kashman; D Neumann; E Rovida; P Dello Sbarba
Journal:  Cell Cycle       Date:  2015       Impact factor: 4.534

Review 2.  Recent N-atom containing compounds from indo-pacific invertebrates.

Authors:  Yoel Kashman; Ashgan Bishara; Maurice Aknin
Journal:  Mar Drugs       Date:  2010-11-10       Impact factor: 5.118

Review 3.  Recently confirmed apoptosis-inducing lead compounds isolated from marine sponge of potential relevance in cancer treatment.

Authors:  Magbubah Essack; Vladimir B Bajic; John A C Archer
Journal:  Mar Drugs       Date:  2011-09-20       Impact factor: 6.085

Review 4.  A Survey of Marine Natural Compounds and Their Derivatives with Anti-cancer Activity Reported in 2012.

Authors:  Wamtinga Richard Sawadogo; Rainatou Boly; Claudia Cerella; Marie Hélène Teiten; Mario Dicato; Marc Diederich
Journal:  Molecules       Date:  2015-04-20       Impact factor: 4.411

Review 5.  Cancer and apoptosis: The apoptotic activity of plant and marine natural products and their potential as targeted cancer therapeutics.

Authors:  Gul-E-Saba Chaudhry; Abdah Md Akim; Yeong Yik Sung; Tengku Muhammad Tengku Sifzizul
Journal:  Front Pharmacol       Date:  2022-08-10       Impact factor: 5.988

Review 6.  Development of Marine-Derived Compounds for Cancer Therapy.

Authors:  Weimin Zuo; Hang Fai Kwok
Journal:  Mar Drugs       Date:  2021-06-15       Impact factor: 5.118

7.  Derivatives of salarin A, salarin C and tulearin A--Fascaplysinopsis sp. metabolites.

Authors:  Lee Goren Zur; Ashgan Bishara; Maurice Aknin; Drorit Neumann; Nathalie Ben-Califa; Yoel Kashman
Journal:  Mar Drugs       Date:  2013-11-11       Impact factor: 5.118

Review 8.  Marine Sponge Natural Products with Anticancer Potential: An Updated Review.

Authors:  Cinzia Calcabrini; Elena Catanzaro; Anupam Bishayee; Eleonora Turrini; Carmela Fimognari
Journal:  Mar Drugs       Date:  2017-10-13       Impact factor: 5.118

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.